Cancer Genetics: A Leader in Precision Oncology Diagnostics

Jun. 19, 2017
Cancer Genetics (NASDAQ: CGIX) combines genomic and immune market testing to improve patients outcome and accelerate the discovery of new therapeutics ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market